ライフサイエンスコーパス: infection rate

1 ates, plate exposure rate, or recipient site infection rate.

2 etained original hardware had a 11.3% repeat infection rate.

3 neutropenia, although without an increase in infection rate.

4 ases the inclusion size but has no effect on infection rate.

5 d key epidemiological quantities such as the infection rate.

6 ause of the unpredictable variability of the infection rate.

7 thin nonciliated cells despite a low initial infection rate.

8 applied lockdown restrictions to reduce the infection rate.

9 ogen to determine the effect of dose on tick infection rate.

10 y, making it difficult to assess its overall infection rate.

11 by an extraordinarily high blood parasite co-infection rate.

12 95% CI, 4.8-6.0-fold) increase in the vector infection rate.

13 significant racial and ethnic disparities in infection rates.

14 lity and may have decreased secondary fungal infection rates.

15 low-dose IV iron groups exhibited identical infection rates.

16 ention bundle compliance and changes in MDRO infection rates.

17 of magnitude larger than activation and new infection rates.

18 utcomes of infants living in areas with high infection rates.

19 e sex ratio was not associated with mosquito infection rates.

20 ll as semen itself, can markedly enhance HIV infection rates.

21 her than the N. gonorrhoeae and T. vaginalis infection rates.

22 VID-19 prevalence and dynamically increasing infection rates.

23 envelope protein correlate with reduced HIV infection rates.

24 y predispose them to higher colonization and infection rates.

25 gambiae and Anopheles funestus survival and infection rates.

26 unlikely to account for such variation in CO infection rates.

27 oprevalences, in addition to those with high infection rates.

28 5% confidence intervals (95% CIs) to compare infection rates.

29 o estimate real-time circulating, per-capita infection rates.

30 ion and possible reductions in surgical site infection rates.

31 rtment (ED), and hospital levels to estimate infection rates.

32 uding symptomatic and asymptomatic) seasonal infection rates.

33 123 facilities were used in the analysis of infection rates.

34 rgent settings was associated with increased infection rates.

35 be important in capturing the true influenza infection rates.

36 t detrimental impact on UC and urinary tract infection rates.

37 In nonimmune adults, this results in 100% infection rates.

38 with no difference in Clostridium difficile infection rates.

39 les [e.g., length of hospital stay (LOS) and infection rates].

40 We varied all parameters, including the infection rate (0.1-20%), proportion asymptomatic (10-80

41 Additionally, wound infection rate (32.3% vs 12.4%, P < 0.0001) and transfus

42 The re-infection rate (95% CI) in pooled analysis of eight one-

43 The MRSA infection rate across the predischarge and 180-day postd

44 ally for comparison of healthcare-associated infection rates across institutions.

45 The infection rate after cranial bone flap replacement range

46 s showed a significantly lower surgical site infection rate after laparoscopic surgery (OR = 0.19; 95

47 n of central catheter-associated bloodstream infection rates after the stepwise implementation of chl

48 ssion of mCherry and Luc are correlated with infection rate, allowing the monitoring of RSV multiplic

49 e was associated with a higher TV persistent infection rate among those receiving the single-dose tre

50 r, FcgammaRIIIa genotype was associated with infection rate among vaccinees (P = .035).

51 ealth measures did not reduce the SARS-CoV-2 infection rate among wearers by more than 50% in a commu

52 ose for both age groups, with much higher re-infection rates among children compared to adolescents a

53 Our model also correctly predicts higher infection rates among disadvantaged racial and socioecon

54 ized driveline protocols, leading to reduced infection rates among MCS recipients.

55 HIV infection rates among men who have sex with men (MSM) in

56 pe DI was frequent and comparable to primary infection rates among MSM in San Diego; however, superin

57 iGAS infection rates among people with documented IDU or home

58 We estimated national iGAS infection rates among PWID and PEH.

59 ound no evidence that IVM reduced Plasmodium infection rates among surviving mosquitoes, the mosquito

60 estimates of anal human papillomavirus (HPV) infection rates among young men who have sex with men (Y

61 Results indicated that FLEs-Hd had 100% infection rate and a perfect vertical transmission in H.

62 l) have been shown to beneficially influence infection rate and clinical outcomes in surgical patient

63 To assess the true dengue infection rate and disease control efforts in Singapore,

64 Both parameters readily yield the peak infection rate and means for flattening the curve, which

65 eristics, treatments, and outcomes including infection rate and mortality between the groups.

66 seasonal vaccination programme would affect infection rate and mortality.

67 dysregulation, which results in an increased infection rate and reduced effectiveness of vaccination.

68 in (a PG synthesis inhibitor) leads to lower infection rates and aberrant cell shapes, suggesting tha

69 effective in reducing healthcare-associated infection rates and are increasingly used to ensure the

70 pestis phoP-negative mutants achieved normal infection rates and bacterial loads in the flea midgut b

71 hat promote parasite transmission may impact infection rates and community assembly of vector-transmi

72 Using data on fishery landings, fish infection rates and consumption habits of the Spanish po

73 ated immune alterations associated with high infection rates and diminished protection following vacc

74 t Supporting behaviours were linked to lower infection rates and Envisioning change behaviours were l

75 that they complete the life cycle with high infection rates and give rise to fluorescent mosquito st

76 t phage with relatively long lifetimes, high infection rates and large burst sizes; (ii) large, stabl

77 epilepticus; furthermore, it portends higher infection rates and longer hospitalizations.

78 ction, it may also be associated with higher infection rates and malignancy risk.

79 antibodies provide one method for estimating infection rates and monitoring the progression of the ep

80 evention strategies in an effort to decrease infection rates and morbidity due to Toxocara.

81 Infection rates and parasite diversity also tended to be

82 Infection rates and parasite diversity exhibited conside

83 ients, offering an explanation for increased infection rates and possible long-term side effects asso

84 Overall infection rates and rates of RTI, skin and soft-tissue i

85 and additionally reduces extremity volumes, infection rates and reliance on outpatient therapy.

86 thod and two observed data streams, mosquito infection rates and reported human WNV cases.

87 Central catheter-associated bloodstream infection rates and safety outcomes (central catheter in

88 hat neutrophil dysfunction may underlie high infection rates and sepsis postburn; however, neutrophil

89 on simulated trees from different networks, infection rates and turnover rates.

90 associated with significantly reduced CAUTI infection rates and urinary catheter days.

91 Other secondary end points included death, infection rate, and dose of an erythropoiesis-stimulatin

92 robustly reduced infarct volumes, decreased infection rate, and increased long-term survival of 2D2

93 Organ failure, infection rate, and mortality did not differ between gro

94 plication rate within 1 week, recipient site infection rate, and plate exposure rate to free fibula f

95 and their impact on the patients' survival, infection rate, and use of dialysis were assessed.

96 l venous catheter use, Clostridium difficile infection rates, and hospital length of stay.

97 diatric long-term care facilities, calculate infection rates, and identify risk factors for respirato

98 by fewer symptomatic cases of malaria, lower infection rates, and lower parasite densities compared t

99 Infection rates, antibacterial envelope effectiveness, i

100 ed to have acute or chronic giardiasis, with infection rates approaching 90% in areas where Giardia i

101 d herpesvirus (KSHV) is globally widespread; infection rates are as high as 80% in parts of sub-Sahar

102 While infection rates are currently low, ZIKV remains a public

103 LOS and infection rates are decreased in LVHR, but overall compl

104 HEV infection rates are dynamic in England and Wales, influe

105 Accurate forecasts of mosquito infection rates are generated before peak infection, and

106 t major trauma-related fractures, deep wound infection rates are high.

107 the prediction that it will be favoured when infection rates are high.

108 e is controversy over whether osteoarticular infection rates are increasing or decreasing.

109 With current systems, infection rates are likely to decline without meaningful

110 Finally, we show that transmission and infection rates are not affected by sfRNA after intratho

111 d organ system or site), the plausibility of infection (rated as none, possible, probable, or definit

112 irective central line-associated bloodstream infection rates associated with a unit increase in nursi

113 ificant difference in the deep surgical site infection rate at 90 days (11.4% [72 of 629 patients] in

114 or hernia recurrence and postoperative wound infection rates at 24 months, and the EQ-5D and Short Fo

115 The comparison of acquired infection rates between groups was adjusted for differen

116 There was no difference in infection rates between studies with low or high baselin

117 Comparison of infection rates between the two groups was a prespecifie

118 ce in complications, including urinary tract infection rates, between those using single or multi-use

119 nd parasitised RBCs, RBC age preference, RBC infection rate, burst size, and within-RBC interference.

120 e coinoculation of BYDV-PAV lowered CYDV-RPV infection rate, but the reverse was not true.

121 iotic prophylaxis (AP) reduces surgical site infection rates, but prior data suggest variability in u

122 coatings on orthopaedic implants may reduce infection rates, but should not be to the detriment of r

123 gery in obese patients reduces surgical site infection rate by 70%-80% compared with open surgery acr

124 We aimed to understand the infection rate, clinical presentation, clinical outcomes

125 d to compare re-infection (recurrent and new infections) rates; clinical measures of function and pai

126 group testing on a massive scale to monitor infection rates closely and continually in a population,

127 n feeding assays resulted in higher mosquito infection rates compared to membrane feeding assays (odd

128 ive, reduce surgical time and post-operative infection rates compared with traditional glaucoma proce

129 nificant efficacy (RV144) found that reduced infection rates correlated with the level of nonneutrali

130 By October to December 2007, the infection rate declined to 1.33 in the intervention grou

131 Forty-one before-after studies identified an infection rate decrease (OR, 0.39 [95% CI, .33-.46]; P <

132 However, salivary gland infection rates decreased as the percentage of parasitiz

133 For the low infection rate, decreases (absolute) in mVE per 30 days

134 For the high infection rate, decreases were 5% for A/H1N1, 4% for A/H

135 The wound infection rate did not differ significantly across the 3

136 Adverse events, including secondary infection rates, did not differ between study groups.

137 Infection rates do not decline as expected in some commu

138 10(-8) day(-1); the percent reduction of the infection rate due to the presence of virus-specific ant

139 with diverticulitis have high surgical site infection rates due to nonmodifiable risk factors.

140 Because the observed infection rates for each group were so low, this apparen

141 ce of antiviral antibodies agreed with known infection rates for the corresponding virus based on epi

142 longitudinally to estimate the difference in infection rates for those who were not colonized, those

143 ulted in a sustained reduction in the severe infection rate from 1.17 events per person-year to 0.17

144 The main outcome measure was change in infection rates from baseline to year 3.

145 The CIED infection rate has increased at a time of increased devi

146 pite these interventions, confirmed COVID-19 infection rates have been high in the United Kingdom.

147 Increased infection rates have been reported in ruxolitinib-treate

148 Klebsiella pneumonia infection rates have increased dramatically.

149 tly used techniques are associated with high infection rates, implant erosion and donor site morbidit

150 these data regarding both the increased GAS infection rate in children and the development of protec

151 sing viral specific primers revealed a lower infection rate in dsRNA-expressing algae treated shrimp

152 omastigotes caused a higher initial in vitro infection rate in human or murine macrophages than untre

153 orrhoeae infections, while the M. genitalium infection rate in males was significantly higher than th

154 n immunoglobulin levels, normal B cells, and infection rate in patients with CLL treated with single-

155 Hospitals with high ARB infection rates in 2005 had an excess burden of BSI of 2

156 low cytometric analysis to directly quantify infection rates in bronchial epithelial tissues.

157 are highly context specific, as they reduce infection rates in elective surgery, but possibly increa

158 airs early viral gene expression and reduces infection rates in endothelial cells, fibroblasts, and m

159 duced V3 Abs are associated with reduced HIV infection rates in humans and affect the nature of trans

160 DC dysfunction may result in increased infection rates in ruxolitinib-treated patients.

161 gp120 envelope (Env) correlated with reduced infection rates in studies of HIV, simian-human immunode

162 Similarly, decreased infection rates in surviving S411A Kunjin-infected Culex

163 Reduced parasitic infection rates in the developed world are suspected to

164 app can contribute substantially to reducing infection rates in the population when accompanied by a

165 al viral load, pup mortality, and congenital infection rates in the vaccine and control groups were c

166 f negative pressure wound therapy can reduce infection rates in this setting.

167 ract infections had any measurable effect on infection rates in U.S. hospitals.

168 Key epidemiological parameters including the infection rate, incubation period and scale of dispersal

169 was predicted by recent hospital C difficile infection rates, introduction of mandatory surveillance

170 The county-level HCV infection rate is 4 times higher in minority counties th

171 ection prevention programs, and reporting of infection rates is increasingly required.

172 residual spraying or a vaccine which reduces infection rates is just before the high season.

173 ensitive testing methods, or higher exposure/infection rates is unknown.

174 terature suggesting that MBP does not reduce infection rate, it still is commonly used.

175 Infection rates, knowledge about soil-transmitted helmin

176 ially constrains Leucocytozoon diversity and infection rates, landscape features, such as vegetation

177 ts per 1,000 drainage days (drain-associated infection rate), length of ICU stay, Glasgow Outcome Sca

178 Safety included analysis of infection rates, line malfunctions, temporary hospitaliz

179 nd decreases in human immunodeficiency virus infection rates, little is known about the factors assoc

180 prophylaxis dramatically reduces post-HALDN infection rates, mainly impacting SSIs and LRTIs.

181 time, web-based estimates of local influenza infection rates makes this type of quantitative forecast

182 s, its primary vectors, known as the Minimum Infection Rate (MIR).

183 en, but it does not significantly change the infection rate, mortality, length of stay, or measures o

184 Positive clusters had a 16.0% infection rate, negative clusters 1.1%.

185 adjusted central line-associated bloodstream infection rate of 0.9 (95% confidence interval 0.5-1.5)/

186 895 (21.5%) who received antibiotics had an infection rate of 1.7% compared with 0.7% in the 3261 (7

187 adjusted central line-associated bloodstream infection rate of 1.8 (95% confidence interval 0.9-3.3)/

188 However, an infection rate of 12.2% has been reported following remo

189 3901 (73.5%) with complete compliance had an infection rate of 3.0%, whereas 1408 (26.5%) who were no

190 s 1408 (26.5%) who were not compliant had an infection rate of 4.3% (adjusted relative risk: 0.7; 95%

191 The model estimates a mean infection rate of 76% among recipients who receive one u

192 rrival of the peak, with a predicted maximum infection rate of 85% or greater than the observed rate.

193 is is in contrast to our previously reported infection rate of about 5% among Bangladeshi villagers.

194 With the infection rate of Bordetella pertussis at a 60-year high

195 jor circulating serpins) would determine the infection rate of host cells.

196 amination, which directly contributes to the infection rate of hosts for the between-host sub-system.

197 ved viruses were identified, representing an infection rate of nearly 5%.

198 S incidence with capture rate and hantavirus infection rate of rodent species in Qingdao City, China.

199 idence to rodent capture rate and hantavirus infection rate of rodents were analyzed statistically.

200 ius and Rattus norvegicus and the hantavirus infection rate of these rodent species in the field or r

201 significant among studies reporting baseline infection rates of <1.15 per 1000 catheter-days, and stu

202 75.4% (two-thirds of these studies reported infection rates of 10% or less).

203 idespread, with seven field sites exhibiting infection rates of 30% or greater.

204 more than 5 risk factors was associated with infection rates of 45.8% (c = 0.69).

205 such antibodies were associated with reduced infection rates of HIV, SIV, and SHIV.

206 Furthermore, infection rates of the six host species in the field wer

207 Infection rates of Trypanosoma brucei gambiense in tsets

208 stigated the microbiologic etiology of these infections, rates of recurrent CRBSI, and associated mor

209 (>10 mg/kg) were associated with a lower CMV infection rate on univariate analysis.

210 Yet despite high infection rates, only a fraction of H. pylori-infected i

211 onvertebral fractures, physical performance, infection rates, or cognitive function.

212 demonstrates a steady decline in bloodstream infection rates over time.

213 rder to understand parasite growth rates and infection rates over time.

214 timicrobial resistance (AMR) on regional AMR infection rates over time.

215 ificant relative decrease in the C difficile infection rate (P < .001) (10th quarter adjusted differe

216 was also associated with a 50% reduction in infection rate (P = .003).

217 ls had irreversible atelectasis, higher lung infection rates (P<0.0001) and BAL neutrophil percentage

218 With sharply rising infection rates, patient groups characterized by an enha

219 Infection rates per 100 births were 3.61 (CI, 0.75 to 10

220 Salmonella cells present high infection rates, persistence over inauspicious condition

221 theters have a high CRBSI rate compared with infection rates previously reported in patients receivin

222 Major epidemics in the meningitis belt have infection rates ranging from 100 to 800 per 100 000 popu

223 CoV infections were identified, with annual infection rates ranging from 2.8% to 26% in prospective

224 12 months had an increased rate of incident infection (rate ratio [RR], 5.1; 95% CI, 1.3-19.6]).

225 sease (rate ratio, 3.7; 95% CI, 3.2 to 4.2), infection (rate ratio, 4.7; 95% CI, 4.0 to 5.5), acute d

226 Mosquito infection rates reached 97% following membrane feeding w

227 interrupted time series studies revealed an infection rate reduction 3 months postintervention (OR,

228 Secondary bloodstream infection rates remained unchanged throughout the observ

229 To test whether these heterogeneous infection rates result from evolved differences in immun

230 mortality) of 1.5, 2.0, and 3.0 at differing infection rate scenarios, including full suppression (0.

231 Relationships between infection rates, self-reported compliance, and audits we

232 owever, when analyzing oocyst and sporozoite infection rates separately, the resistant homozygote 119

233 ring 2008-2012 was contact lens use, and the infection rate significantly increased from 40.7% to 52.

234 Moreover, low-risk VV vaccinees had infection rates similar to individuals with high behavio

235 seholds and estimate the household secondary infection rate (SIR) to inform strategies to reduce tran

236 by more than 50% in a community with modest infection rates, some degree of social distancing, and u

237 5.5%, 33.1% and 31.8%, from 2002 onwards the infection rates steadily decreased to 7.3%.

238 accinated low-risk VV subjects had a greater infection rate than low-risk VV placebo recipients (HR =

239 hool-aged children have substantially higher infection rates than adults.

240 plant CMI developed significantly higher CMV infection rates than those deemed to be at low risk with

241 on the extension study resulted in a yearly infection rate that decreased from 4.63 events (95% conf

242 However, the reduced infection rate that resulted from the vaccine used in th

243 In the context of increasing Chlamydia infection rates, the reproductive complications of Chlam

244 -infections are frequent, possibly affecting infection rates through competition or facilitation.

245 Applying the Quest HCV infection rate to annual live births from 2011 to 2014 r

246 The control group also reduced infection rates to <1/1,000 central line days (a 69% red

247 racteristics (e.g., breast milk substitutes, infection rates, underweight, and pubertal timing) diffe

248 t, the donor-risk-index had no impact on the infection rate, use of dialysis or survival.

249 the key components of virus dynamics such as infection rate, virus clearance, viral load, CD4(+) T ce

250 ty to VSV infection as evidenced by elevated infection rates, virus replication in multiple tissue ty

251 The overall catheter-related bloodstream infection rate was 0.2 per 1,000 catheter days.

252 The infant infection rate was 0.75 per 100 births from 1997 to 2010

253 The infection rate was 1.4%, 1.5%, and 2.0% for single, dual

254 -Hispanic whites (P < .001), while the HSV-1 infection rate was 1.7 times higher in non-Hispanic whit

255 8% and 10.5% (p = 0.02) and drain-associated infection rate was 18 and 7.1, respectively (p = 0.0001)

256 The overall 1-year device-related infection rate was 2.4% (16 of 659).

257 The HSV-2 infection rate was 2.6 times higher in non-Hispanic blac

258 vaccine birth dose and the hepatitis B virus infection rate was 4 times lower.

259 The infection rate was 4.1% versus 3.6% in the TV-ICD groups

260 The total infection rate was 40.7% (59/145) in the placebo group a

261 The overall infection rate was 5.3 infections per 1000 resident-days

262 Incident bloodstream infection rate was 9.6 and 8.4 per 1000 hospital days in

263 The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical

264 adjusted central line-associated bloodstream infection rate was calculated for these cumulated line d

265 ge of neuronal and non-neuronal tropism, the infection rate was highest in intermediate progenitor ce

266 Thus, the repeat infection rate was low (1.8%) in those who were reimplan

267 The infection rate was not statistically different on univar

268 The infection rate was significantly higher in the ASB group

269 The infection rate was the same in the two groups.

270 The difference in infection rates was because of lower bacterial (32% vs 4

271 ecause change in mVE was highly dependent on infection rates, we performed simulations using low (15%

272 H. pylori infection rate were 90.26% in these cases, so that 33.65

273 Very low-birth-weight infant infection rates were 16.4% in 2008 and 13.9% in 2009.

274 f 414 patients showed that the postoperative infection rates were 17% (35 of 207) in the nontreatment

275 Thirty-day overall and organ/space infection rates were 17.4% (175) and 8.5% (86).

276 37%) or B (23%) (P < 0.001); cytomegalovirus infection rates were 35%, 20% and 23%, respectively (P =

277 The whole mosquito Plasmodium and sporozoite infection rates were 57% and 14.8% respectively in Obout

278 Surgical site infection rates were also higher among patients with an

279 Infection rates were calculated for each woman-year in c

280 Persistent TV infection rates were compared for women on ART at baseli

281 Catheter infection rates were determined per 1,000 catheter days

282 luated over 180 days; immunogenicity and RSV infection rates were evaluated over 112 days.

283 rimester of pregnancy; however, because ZIKV infection rates were highly variable, most pregnant wome

284 l indicators potentially associated with HCV infection rates were identified.

285 Infection rates were lower in group B compared with grou

286 ) were able to infect neutrophils, while the infection rates were lower than 29%, suggesting that C.

287 Re-infection rates were meta-analysed using random-effect m

288 Hospital-acquired infection rates were not different between the two perio

289 Higher infection rates were recorded in the >2-year and the 1-

290 Surgical site infection rates were significantly higher among people w

291 higher with zanubrutinib, although grade >=3 infection rates were similar in both arms (1.2 and 1.1 e

292 Overall oral SIV infection rates were similar in the gingivitis-induced a

293 nfections occurred with D-RVd, but grade 3/4 infection rates were similar.

294 SR as a VAD indicator may depend on infection rates, which should be taken into consideratio

295 uctuations indicative of seasonal forcing of infection rates, which was likely driven by multiple env

296 Antibacterial and G-CSF prophylaxis reduced infection rates while mandatory hospitalization did not

297 for probable viral infections, and reducing infection rates will help preserve the antibiotics we ha

298 targeted antibiotics may not see changes in infection rates with antibiotic-resistant organisms in t

299 Infection rates with F. necrophorum, group A streptococc

300 We assessed variation in bloodstream infection rates within and between PICUs over a 10-year